| 2026 |
A critical analysis on ENaC inhibitors, unravelling molecular medicinal insights and promising research roadmap in the treatment of cystic fibrosis |
Review essay (rassegna critica) |
Vai |
| 2025 |
Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis |
Review essay (rassegna critica) |
Vai |
| 2024 |
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis |
Articolo in rivista |
Vai |
| 2022 |
GPCR Inhibition in Treating Lymphoma |
Articolo in rivista |
Vai |
